Core Viewpoint - Sichuan Province has introduced measures to promote the development of the pharmaceutical and health industry, focusing on six specific sectors: nuclear medicine, biomedicine, medical devices, sports, modern traditional Chinese medicine, and medical beauty [1][2] Group 1: Support for Innovation and Research - The measures support the establishment of national-level research platforms, including key laboratories for biotherapy and oral disease prevention, as well as major scientific infrastructure for translational medicine [1] - Emphasis is placed on collaboration between academic and research institutions and quality enterprises in the industry chain, particularly in areas like malignant tumors and emerging infectious diseases [1] - The initiative aims to develop innovative drug projects in fields such as cell therapy, gene therapy, synthetic biology, and brain science, along with a focus on creating a key research and development catalog for innovative drugs [1] Group 2: Financial Support and Incentives - The measures integrate resources to provide financial support for key industry projects, including a program that offers up to 40% of the total contract amount for project funding, with a maximum of 20 million yuan per project [2] - Specific subsidies are outlined for nuclear medicine projects, with a maximum subsidy of 20% of the project investment and a cap of 2 million yuan, while research projects can receive up to 30% of their R&D investment, capped at 1 million yuan [2] - Additional financial incentives include 40 million yuan annually for the top five cities in sports industry development, and up to 200,000 yuan for outdoor sports base construction projects [2] Group 3: Streamlined Processes - The measures establish a "key project service team" for pharmaceuticals and medical devices, ensuring that innovative drugs complete network review within 15 working days [2]

●泸州港完成集装箱吞吐量全省第一 位于泸州的西南医科大学对心脑血管疾病、癌症等"四大慢性病"研究长达数十年。西南医科大学供图 四川行走科技有限公司实验训练场内，工作人员正模拟康复医疗器械设备训练。记者 郝飞 摄 数据里的"硬核"泸州 城市硬实力 两个"三十定律"，在这座川南重镇，正在发生奇妙共振。 10年 ●再生稻有收面积全省第一 ●泸州老窖"中国企业500强"排位连续4年晋升 ●北化股份硝化棉产销规模全球第一 ●四川首台金属3D打印工业母机去年在泸州下线 ●全市有医疗卫生机构4400余家，医疗卫生条件居全省第二 ●西南医科大学附属医院核医学科新型核素治疗量全国第一 医药研发领域有个"三十定律"，即一款新药的研发，需要耗时10年、花费至少10亿美元、但成功率仅有 10%。就是这样一条费时费力的赛道，泸州却提出要打造医药健康千亿产业。 底气从哪里来？近日，四川日报全媒体《"城"势而上——"经济大省挑大梁"四川进行时》采访组深入当地调 研采访后发现，这是泸州结合国家和省委赋予的发展定位，在综合研判产业基础、优势短板、发展前景后，作出 的慎重选择。 不仅如此，在泸州还存在另一个"三十定律"——允许企业投资10年后没 ...